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The first component of complement (C 1)1 circulates in plasma as a macromolecular 
complex of three distinct proteins designated Clq, Clr, and Cls (1). Clq, the largest 
subcomponent of the three (tool wt 410,000),  consists of six subunits of three chains 
A, B, and C  (mol wt 21,000-24,000)  and is unique among the complement proteins 
with 40% of its amino acid sequence similar to collagen (proline, hydroxyproline, and 
hydroxylysine) (2, 3). Activation of the calcium dependent C 1 complex occurs when 
Clq binds to the Fc portion of IgG or IgM (4, 5) presumably causing a conformational 
change in Clq (6). Clr, a protein with fl-mobility (7), is present in plasma as a single 
chain protein in its zymogen form (tool wt 190,000 [8] or 166,000 [9]). It is postulated 
that activation of Clr to CI~ (mol wt 95,000  [8]  or  107,000  [9]) is initiated by the 
conformational change in C lq (6). A peptide bond is cleaved generating a two chain 
disulfide-linked molecule (mol wt 58,000  and 36,000  [8,  9])  with y-mobility (7).  A 
mechanism  similar  to  Clr  activation  occurs  when  Cls  (tool  wt  87,000)  binds  to 
C 17 and is activated by cleavage of the peptide chain generating the two-chain (tool 
wt 58,000  and 29,000  [8, 9]) serine esterase CI§. 
The sites of biosynthesis of most of the complement proteins have been identified. 
However, because of conflicting findings in studies of C 1 biosynthesis (10-21), the cell 
type primarily responsible for the synthesis of this component has not been clearly 
identifiable. To resolve the apparent discrepancies in these findings we compared the 
capacity of human fetal intestine columnar epithelium, bladder transitional epithe- 
lium, skin and lung fibroblasts, blood monocytes and several primary cell c/lltures 
from biopsies of the urogenital tract to synthesize C1. All three cell types (epithelia, 
fibroblasts, and monocytes) tested synthesized hemolytically active C 1, but epithelial 
cells produced 400-3,700 times more active C 1 than either fibroblasts or monocytes. 
Radiolabeled C lq, C lr, and C ls were detected in culture media from both epithelial 
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and mesenchymal cells.  However, only columnar epithelial cells produced C lq with 
a subunit structure similar to reported values for Clq in serum  (2, 3). Clq from the 
other  lines  had  a  larger  apparent  molecular  weight  than  serum  Clq  and  did  not 
dissociate  like serum Clq.  Cls  from all cell  types tested  had an apparent molecular 
weight greater than serum Cls. 
Materials and Methods 
Media and Reagents.  Dulbecco's minimal essential medium (D-MEM),  2 medium 199 (M 199), 
medium  199 special (M199 special; lacking valine, leucine, isoleucine, lysine, and glutamine), 
Earle's  minimal  essential  medium  (E-MEM),  fetal  bovine serum,  mycoplasma  free  (FBS), 
glutamine, nonessential amino acids (NEAA), penicillin (10,000  U/ml)-streptomycin (10,000 
pg/ml)-fungizone  (25  /xg/ml)  (antibiotics), Hanks'  balanced  salt  solution  (HBSS),  trypsin- 
versene, and guinea pig serum were purchased from Microbiological Associates, Walkersville, 
Md.  Sheep erythrocytes (E)  were purchased from Scott Laboratories, Fiskeviile, R.I.  Bovine 
serum albumin (BSA), phosphorylase a, phenylmethyl sulfonyl fluoride (PMSF), insulin, and 
cycloheximide were purchased from Sigma Chemical Co., St. Louis, Mo.; creatine kinase and 
glutamate dehydrogenase were purchased from Boehringer Mannheim Biochemicals, Indian- 
apolis, Ind.; fl-galactosidase and carbonic anhydrase were purchased from Worthington Bio- 
chemical Corp., Freehold, N.J. A tritiated mixture of 15 amino acids consisting of: 80 #Ci L- 
alanine, 70 #Ci L-arginine, 80 #Ci L-aspartic acid, 125 ffCi L-glutamic acid, 40 ffCi glycine, 15 
~Ci L-histidine, 50 btCi I.-isoleucine, 140 p,  Ci L-leucine, 60 ffCi L-lysine, 80 ~Ci L-phenylalanine, 
50 ~Ci L-proline, 40/~Ci L-serine, 50/~Ci t.-threonine, 40 ~tCi L-tyrosine, and 80 ffCi  L-valine, 
and Biofluor were purchased from New England Nuclear Corp., Boston, Mass. 
Antisera.  Goat  antiserum  to  human  Clq,  Cls,  and  IgG  were  obtained  from  Atlantic 
Antibodies, Westbrook, Maine. Initially, rabbit antiserum to human C lr was a gift from Dr. 
Robert Ziccardi, Research Institute of Scripps Clinic, La Jolla, Calif. In later experiments, goat 
antiserum to human Clr was obtained by adsorption of a  crude antiserum to Clr (Atlantic 
Antibodies), with Sepharose 6B-linked pseudoglobulin, C ls and C3. The globulin fraction of 
each antiserum was obtained by precipitation with 18% sodium sulfate at 37°C. The precipitate 
was dissolved in 100 mM KC1-50 mM Tris(hydroxymethyl)aminomethane (Tris), pH 7.5 (Tris- 
KCI  buffer),  dialyzed against  the  Tris-KCl  buffer  and  centrifuged  (10,000  g)  before  use. 
Euglobulin and pseudoglobulin serum fractions, which served as carriers for immunopreeipi- 
rations, were obtained by overnight dialysis of human  serum against  100  vol of 0.065  ionic 
strength sodium acetate pH  5.5  at  4°C.  The  euglobulin precipitate was removed from  the 
supernate  (pseudoglobulin)  by  centrifugation  (10,000  g,  20  min)  and  the  euglobulin  was 
dissolved in 0.1 the serum volume with  150 mM NaCI. Precipitin curves of antiserum to Clq, 
C lr, and C ls against euglobulin and anti-IgG with pseudoglobulin were done to determine the 
amount of antibody and antigen giving 30 #g of precipitate at equivalence. 
Cell  Cultures.  The  methods  for culture of primary transitional epithelial cells have been 
briefly described  (21).  Surgical  samples  in  HBSS  and  antibiotics were  obtained  from  Dr. 
Murray  M.  Bern,  New  England  Deaconess  Hospital, Boston,  Mass. Transitional cells were 
carefully scraped from the tissue and washed in HBSS with antibiotics. Viability was estimated 
by trypan blue exclusion and a maximum of 5  ×  105 viable cells seeded into 25 cm  2 T-flasks 
(Falcon Labware Div., Becton-Dickinson, Oxnard, Calif.) containing  10%  E-MEM  (vol/vol) 
heat-inactivated (56°C, 30 min) FBS, glutamine, and antibiotics, and incubated at 37°C in a 
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humidified 5% CO2/95% air atmosphere. Cultures were monitored daily and fed  with fresh 
medium at least twice weekly, and were maintained for at least 8 wk before transfer to allow 
establishment of the monolayer. If present, fibroblasts were selectively removed by a  2-min 
trypsin-versene treatment as described by Owens et al. (22). Because of nonspecific lysis which 
occurs in the hemolytic assay where bacterial or fungal products were  present, contaminated 
cultures were not used for any experiment. 
The human fetal intestine, Hs0074,  fetal intestine-agammaglobulinemia,  Hs0677,  normal 
bladder transitional epithelium, Hs0767,  and normal lung fibroblasts, Hs0907,  were provided 
by contract E-73-2001-N01  within the Special Virus-Cancer Program, National Institutes of 
Health, Public Health Service through the courtesy of Dr.  Helene S. Smith, Peraha Cancer 
Research Institute, Oakland, Calif. These cells were fed twice weekly with D-MEM, 10% (vol/ 
vol) heat-inactivated FBS,  l0 #g/ml bovine insulin, and NEAA. Monolayers of =7.5  ×  105 
cells/75 cm  2 flask formed weekly  and were transferred  1:2 with trypsin-versene. All cultures 
were in passage  numbers from 4 to 30. The adult human skin fibroblast cultures in passages 4 
and 5 were  maintained in M199,  15% FBS, and antibiotics at 37°C, 5% CO2/95% air. Blood 
monocyte cultures were established as described by Einstein et al. (23) and maintained for 4 wk 
in vitro before use. 
Medium from primary cultures was removed at various intervals, concentrated 5- to 10-fold 
by  dialysis against  sucrose  and  dialyzed overnight  against  l  mM  Veronal-buffered saline 
containing 1 mM MgCI2 and 1.5 mM CaCI2, pH 7.35 (VBS). Samples were either assayed for 
C1 hemolytic activity within 24 h, or stored at -80°C. 
For radiolabeling experiments, cells  were  grown to  =75%  confluency in the  appropriate 
culture medium. The D-MEM complete medium from the fetal intestine (Hs0074 and Hs0677), 
bladder transitional epithelium (Hs0767),  and lung fibroblast (Hs0907)  cultures was removed 
and replaced with D-MEM containing 10% (vol/vol) HBSS,  10 #g/ml insulin, and from  10.0 
to 100 gCi/ml of all-amino acids.  M199 special containing antibiotics and 100/tCi/ml of the 
3H-amino acid mixture was used for the fibroblast and monocyte cultures. All cultures were 
supplemented with  10% (vol/vol) heat-inactivated FBS which had been dialyzed against four 
changes of 100 vol of deionized distilled water and two changes of 100 vol of:150 mM sodium 
chloride and sterilized by Millipore filtration. At timed intervals medium was decanted, made 
2 mM in PMSF by using a 200-raM stock solution of PMSF, and assayed within 24 h or stored 
at -80°C. 
Assay of Culture Medium for CI Hemolytic Activity.  Samples of unconcentrated medium from 
bladder and intestinal epithelium, monocyte and skin and lung fibroblast cultures or concen- 
trated dialyzed primary culture medium were assayed for CI by a modification of the CI assay 
(24). Dilutions of culture medium were made in isotonic Veronal-buffered sucrose with gselatin, 
calcium, and magnesium, pH 7.35 (VBS sucrose).  Equal vol (0.2 ml) of EAC4 (1.5 ×  10  cells/ 
ml) and culture medium (or dilutions) were incubated at 30°C for  10-60 rain with shaking. 
VBS sucrose  (1 ml), warmed to 30°C, was added, the cells centrifuged, washed again with 1 ml 
warmed VBS sucrose, and centrifuged. The pellet was resuspended in 0.4 ml V.  BS sucrose and 
0.2 ml transferred to a clean tube. Purified guinea pig C2 (1.0 ml, 50 effective  molecules/cell) 
in  VBS  sucrose  was  added  and  incubated with  shaking  at  30°C  for  10  min.  Terminal 
complement components (0.3 ml), C3-C-9, were supplied by adding guinea pig serum diluted 
1:35 (vol/vol) with isotonic Veronal-buffered 1 mM EDTA with gelatin, pH 7.35 0.3 ml EDTA 
buffer. After 1 h at 37°C,  1 ml of ice-cold  150 mM NaC1 was added, the mixture centrifuged 
and the  A4azxcm of the supernate read.  Effective  molecules (era)  of C1  were calculated by the 
method outlined by Borsos and Rapp (25). 
Measurement of C1 activation in culture medium was performed with a slight modification 
of a previously described procedure. EAC4 (1.5 ×  l0  s cells/ml) were added to an equal vol of 
1:10 dilutions of culture medium and incubated at 30°C with shaking. At timed intervals 0.8 
ml of EAC4 and medium from each sample flask were removed and washed twice with 2.0 ml 
of warmed VBS sucrose. The pellet was resuspended in the original volume of VBS sucrose  (0.8 
ml) which was divided equally among four tubes. The assay for C1 activity was then performed 
as described above. 
Isolation of C]from IgG-Sepharose.  The procedure of Assimeh et al. (26) as modified by J. M. 
Andrews (unpublished data)  using IgG coupled to p-azo-benzyloxyethyl-sulfonoethyl-Sepha- 
rose-6B (IgG-Sepharose) was used to purify C1.  Each  10 ml of fivefold concentrated dialyzed 1010  Ct  SYNTHESIS  BY  EPITHELIAL AND MESENCHYMAL  CELLS 
medium from various time periods was added to  1 g of IgG-Sepharose and stirred for  1 h  at 
4°C.  Medium was removed from the resin on a  Buchner funnel, the resin was suspended in 
VBS and poured into an appropriate sized column. The resin was washed first in a volume of 
VBS equivalent to the starting volume of medium and the CI was eluted with 200 mM  1,3- 
diaminopropane-200 mM  borate-l,000  mM  NaC1,  pH  7.4  (diamine eluate).  After dialysis 
against two changes of 100  vol of VBS the eluates were tested for C1  hemolytic activity as 
described. 
Inhibition of Synthesis by Cycloheximide.  Three cultures of bladder epithelium (Hs0677), seeded 
with equal cell numbers, were grown for 3 days. At that time the medium was decanted and 
replaced with  10/~Ci/ml of 3H-amino acids. Two cultures were also exposed to 5/tg/ml of 
cycloheximide. 24 h  later all media were removed, the cultures washed with HBSS and fresh 
medium containing 10 #Ci/ml of'~H-amino acids was added. One of the cycloheximide cultures 
was again incubated with 5/~g/ml of cycloheximide. Media were removed at 48 h, and all were 
assayed for hemolytic activity as described previously, and  subcomponent  levels were deter- 
mined by immunoprecipitation. 
Assay of Total Protein Synthesis.  5-/d samples of each of radiolabeled culture medium were 
precipitated on Whatman 3 MM filter paper discs with 10% trichloroacetic acid-10 mM leucine 
and counted in a  Searle Mark III Liquid Scintillation Spectrometer (Searle Diagnostics Inc., 
subsid, of G.  D.  Searle & Co.,  Des Plaines, Ill.), according to the procedure of Roberts and 
Patterson (27) as modified by Hall and Colten (28). 
Immunoprecipitation.  A  modification of the procedure of Hall and Cohen  (29) was used for 
precipitation of C l q, C l r, C Is, and IgG from culture media. Each reaction mixture consisted 
of  100-700  /xl of radiolabeled culture medium  made  10  mM  with  EDTA,  the  appropriate 
amounts of euglobulin or pseudoglobulin, and either anti-C l q, anti-C1 r, anti-C l s, or anti-IgG 
antiserum. This mixture was incubated at 37°C for 3 h  and overnight at room temperature. 
The immune precipitates were washed three times in cold 50 mM Tris-100 mM KCI pH  7.5 
and twice in cold 150 mM NaCI. Total radioactivity was estimated by scintillation spectrometry 
after dissolving in 200/d of 0.1  N  NaOH  and transferring the solution to a scintillation vial 
containing  5  ml  Biofluor  (New  England  Nuclear  Corp.).  Molecular  weights  and  subunit 
structures were estimated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis 
(PAGE) as described below. 
SDS-PAGE.  The procedure of Weber and Osborn  (30)  was followed for the preparation 
and electrophoresis of 5.0 and 7.5% polyacrylamide-SDS gels. Immune precipitates dissolved in 
sample buffer were boiled for 2 rain, reduced by boiling for 2 min in 2% 2-mercaptoethanol, 
and alkylated with 40/tl/100-#l samples of 0.5 M  iodoacetic acid for 30 min at 37°C. Gels were 
sliced into  1.5-mm slices with a  Savant autogel divider (Savant Instruments, Inc., Hicksville, 
N.Y.) and dispensed into scintillation vials containing 5 ml Biofluor in an LKB 2112  Redirac 
fraction collector (LKB  Instruments,  Inc., Stockholm, Sweden).  The  vials were counted  by 
liquid scintillation spectrometry and the counts were plotted as Rf, the '~H-protein migration 
divided by the dye marker migration times 100. Rr values for standard markers/8-galactosidase 
(130,000),  phosphorylase a (94,000),  BSA (68,000),  glutamate dehydrogenase (54,000),  creatine 
kinase (40,000),  and carbonic anhydrase (29,000)  were estimated from Coomassie Blue stained 
gels and were used for calculating molecular weights of the radiolabeled peaks. 
Results 
Production of Cl by Prirna~y Cultures.  Transitional epithelial cells were obtained from 
biopsies of bladder, renal pelvis, and ureter. Primary cultures of each synthesized and 
secreted hemolytically active C1  while under similar conditions a  lymphoma, kidney 
epithelium, and  hypemephroma  failed to produce detectable C1  activity (Table I). 
The  transitional  epithelial cell  cultures  secreted  2  ×  10a-l.8  ×  10 l°  effective  C1 
molecules (em)/cuhure  per day.  In  two separate transitional epithelial cell cultures 
obtained from renal pelvis it was possible to precisely calculate the rate of active C 1 
synthesis per cell; i.e., 5.7  X  10  a and 2.9  ×  10 a em/cell per h, respectively, during the 
first 2 days in vitro. KATHERINE M.  MORRIS,  HARVEY R.  COLTEN, AND DAVID H.  BING 
TABLE  I 
Production of Hemolytically Active CI in Primary Cell Cultures 
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em/cuhure  em/cuhure per  em/cell per h 
Culture  ×  10 -I°  24 h  ×  10  -w  ×  10  -~ 
Transitional epithelium: 
Renal pelvis:  1 
Day 0-2  3.31  1.66  5.70 
Day 8-15  12.60  1.80 
Day 16-19  1.51  0.50 
Renal pelvis: 3  0.45  0.23 
Ureter: 4 
Day 0-2  1.79  0.60  1.93 
Ureter:  1  3.40  1.10 
Ureter: 6 
Day 0-2  0.04  0.02  1.0 l 
Kidney parenchyma  0,01  <0.003 
Tumor cell cultures: 
Renal pelvis: 2 
Day 0-4  4.44  1.11  2.88 
Bladder epithelium  <0,001  -- 
Itypernephroma: 8  0.003 
Lymphoma  <0.001 
TABLE II 
Biosynthesis of Hemolytically Active CI and Total Protein by Epithelial and Mesenchymal Cells in Culture 
Total protein (TCA  em/cuhure per  Cell number  era/cell per h 
Culture  24 h  X  10  -"~  X  106  X  10  -a  ppt cpm) per culture 
per 24h  ×  10 "n 
Bladder  transitional  epithelium  57.9  0.5  483.33  2.30 
(Hs0767) 
Fetal intestine epithelium (Hs0474)  75.9  0.5  633.33  2.08 
Skin fibroblasts  1  0.04  1.0  0.17  3.40 
Skin fibroblasts  2  0.07  1.0  0.29  2.06 
Lung fihroblasts  (Hs0907)  0.22  0.7  1.15  2.00 
Blood monocytes 11  0.02  1.0  0.83  0.80 
Blood monocytes 21  0.29  1.0  1.21  0.43 
A  comparison  of the capacity  of several  epithelial  and  mesenchymal  cell cultures 
(low  passage  and  primary)  to synthesize  C I  and  total  protein  is shown  in  Table  II. 
Bladder  transitional  epithelial  and  columnar  epithelial  cells  from  fetal  intestine 
synthesized  and  secreted  400-3,700  times  as  much  hemolytically active C 1 as  fibro- 
blasts  from skin  and  lung.  Monocytes  synthesized  approximately  three  to  five times 
less  total  protein  (TCA  precipitable  [ppt]  cpm)  and  400-760  times  less  active  C1 
compared  to the epithelial cell cultures. 
Activation  of C1  in  Culture  Medium.  As  shown  in  Fig.  1,  medium  from  bladder 
transitional  epithelial  cells contained  both  C1  and  C1.  By  2  min,  there  were  2.3  × 
10 t° em/culture  in the bladder medium  which increased to 5.2  ×  10 n  em/culture  by 
60 min. This activity did not  increase after 60 min and  was  inhibited  by addition  of 
anti-C1  antiserum  to  the  initial  incubation  mixture  (data  not  shown).  Although 1012 
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TABLE III 
Cycloheximide Inhibition of C I and Protein Synthesis 
Bladder transitional epithelium*  era/cell per h 
X  10  -s 
cpm in 30/Lg specific immunoprecipitate 
Clq  Clr  Cls 
Medium/medium  1,260/1,700~:  4,150/5,300  3,250/4,200  2,700/3,500 
Cycloheximide/cycloheximide  575/720  0/0  150/150  0/200 
Cycloheximide/medium  800/1,420  0/2,700  0/2,700  0/1,300 
* Cultures were grown in medium containing 5 #g/ml cycloheximide and 10 p,  Ci/ml all-amino acids. At 
24 h the medium was removed, the monolayer washed with HBSS and replaced with fresh medium, with 
or without 5 ~g/m[ cycloheximide, and 10 pCi/ml :JH-arnino  acids and grown for 48 h before collection 
of medium. Assays were performed as reported in the Materials and Methods section. 
:~ The first number  equals  24 h and the second number,  48  h after washing and replacing with  fresh 
medium containing  10 ffCi/ml :~H-amino  acids and containing or lacking cycloheximide. 
medium  from  fibroblast and  monocyte cultures  contained  hemolytically active C1 
(2.7  X  108  and  3.4  X  l0  s  em/ml)  there was  no  detectable zymogen  form  of C1  in 
these culture media. The possibility that fibroblast and monocyte cultures synthesized 
C lr and C l s  but  no functionally active C lq was tested. Accordingly, 10/~g purified 
Clq  was  incubated  at  32°C  for  15  rain  with  several  dilutions  of  fibroblast  and 
monocyte culture medium and then assayed for C 1 activity in the usual manner. This 
did not result in generation of detectable hemolytic C 1 activity in any of the mixtures. 
A  positive control consisting of purified C lq, C l r, and C l s, assayed in the identical 
manner yielded 2.52  X  10 l° em/ml of C1  activity. 
Inhibition of de novo Protein and C1  Synthesis  by Cycloheximide.  The data in Table III 
show that addition of cycloheximide to transitional epithelial cell cultures resulted in 
a  decrease in CI  hemolytic activity. In addition, only the cultures without cyclohex- 
imide synthesized  Clq,  Clr,  and  Cls.  The  inhibitory  effect  of cycloheximide was 
reversible. 
Isolation  of Hemolytically Active Cl from  Culture  Medium on IgG-Sepharose.  The results 
of isolation of C I  from culture medium on IgG-Sepharose (as described in Materials 
and Methods) are presented in Table IV. Hemolytically active C1  from bladder and 
intestinal epithelial cell cultures  bound  to  the  IgG-Sepharose and  was  eluted with 
diamine.  A  similar binding and  elution of authentic  C1  in  normal  serum  was  also 
observed  in  agreement  with  previously  reported  findings  (26).  Media  from  two 
hypernephromas, a  lymphoma, a  bladder carcinoma, and HeLa cells with no demon- 
strable hemolytically active C i, were fractionated in an identical manner to determine 
whether  C1  was  present  in  quantities  only  detectable in  a  purified  (concentrated) KATHERINE  M.  MORRIS,  HARVEY R.  COLTEN, AND DAVID H.  BING 
TABLE IV 
Isolation of C I Hemolytic Activity on IgG-Sepharose 
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CI Source  Fraction  em X 10  -j° 
Bladder epithelium (Hs0767) 
Fetal intestine (Hs0677) 
Normal serum 
Medium  5.58 
Nonadsorbed  0.008 
Diamine eluant  21.9 
Medium  129 
Nonadsorbed  0 
Diamine eluant  167 
Euglobulln fraction  9,300 
Nonadsorbed  275 
Diamine eluant  11,000 
form or was masked by an inhibitor.  No functionally active C1 was detected. 
Identification  of Subunits  of Clq,  Clr, and  Cls on SDS-PAGE  under Reducing  Conditions. 
Clq subunits synthesized by fetal intestine epithelium  (Hs0074)  (Fig. 2 a) had a size 
(mol wt 20,000-24,000)  and subunit structure similar to those reported for serum C lq 
(2,  3).  Analysis on  SDS-5.6%  PAGE  of reduced  and  alkylated  Clq  from  bladder 
epithelium  (Hs0767)  revealed  major  peaks  of approximately  175,000,  81,000,  and 
72,000  dahons.  A  minor  peak  was  also  evident  at  105,000  dahons  (Fig.  2b).  In 
monocyte  culture  medium  (Fig.  2c)  two  major  peaks  (78,000  and  30,000-36,000 
dahons)  were present. Clq isolated from fibroblast medium had a  molecular size of 
approximately  185,000  dahons  (Fig.  2d).  In  addition,  a  heterogeneous  mixture of 
labeled protein specifically precipitated with anti-C lq antiserum was distributed over 
a  broad range  (35,000-120,000  dahons).  Radiolabel  in control  immunoprecipitates 
(consisting of IgG anti-IgG) distributed uniformly throughout the gel without recog- 
nizable peaks, in this and other experiments (Figs. 2-4). 
As  illustrated  in  Fig.  3a  the  radiolabeled  Clr  synthesized  by  fetal  intestine 
epithelium (Hs0677) distributed in two major peaks with apparent mol wt of 145,000 
and  90,000.  These corresponded  in  size to the  dimer and  monomer Cir.  On  SDS- 
7.5%  PAGE, the major peaks for Clr from monocyte culture medium approximated 
85,000  and 33,000  (Fig.  3 b). Clr isolated from fibroblast and transitional epithelial 
cell culture medium had similar distributions in gels (data not shown). 
SDS-PAGE analysis of C Is isolated from monocyte medium illustrated in Fig. 4 a, 
showed a broad major peak in the area from 20,000 to 40,000 with a smaller peak at 
80,000.  Patterns with the broad major peak in this range were obtained for Cls from 
fetal intestine and bladder epithelium culture medium. Fibroblast cultures produced 
a  molecule  with  subunits  corresponding  to  those  reported  for  Cls  (.7) but  also 
consistently contained a larger molecular species of = 130,000  daltons. 
Discussion 
Early studies on the biosynthesis of complement involved the removal or ablation 
of an organ and measurement of the reduction of whole complement levels in serum 
(31-33).  Improvement in tissue culture techniques and development of methods for 
detection of individual complement proteins allowed studies of complement synthesis 
in  vitro.  Cohen  et  al.  (10,  11)  used  the  hemolytic  assay  for  (21  (27)  to  identify 
biologically active C 1 in short term organ and cell cultures of guinea pig and human 
intestine. Although they could detect incorporation of ~4(3-amino acids into a molecule 1014 
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FIG. 2.  SDS-PAGE  of immunoprecipitates of reduced and  alkylated  Clq.  (a)  Fetal intestine 
columnar epithelial cell culture medium (10 #Ci/ml 3H-amino acids; 24 h); 5.0% polyacrylamide 
gel; peak A: 27,000-32,000, peak B:  19,000-21,000. 0, anti-Clq; ©, anti-IgG. (b) Bladder transi- 
tional epithelial cell culture medium (10 #Ci/ml 3H-amino acids; 24 h); 5.0% polyacrylamide gel; 
peak A: 175,000, peak B:  105,000, peak C: 81,000, peak D: 72,000. D, anti-Clq; [--I, anti-IgG. (c) 
Monocyte culture medium (100 #Ci/ml 3H-amino acids; 24 h); 7.5% polyacrylamide gel; peak A: 
78,000, peak B: 35,000. A, anti-Clq;  A, anti-IgG. (d) Fibroblast culture medium (100/~Ci/ml 3H- 
amino acids; 24 h); 7.5% polyacrylamide gels; peak A: 185,000. 0, anti-Clq; O, anti-lgG. 
functionally similar  to C 1, the cell  type responsible  for synthesis was not identified. 
The development of a  modification of the Jerne plaque technique led to the finding 
that  the  columnar  epithelial  cell  produced  biologically  active  CI  (12).  Additional 
evidence that C 1 found in epithelial  cell cultures was synthesized and not merely the 
result  of release  of preformed  protein  was obtained  in studies  of long-term primary 
suspension cultures of human colon, adenocarcinoma, and transitional epithelial cells 
of the urogenital tract  (13). 
With  the use of autoradiography of precipitin  bands on radioimmunoelectropho- 
resis,  Stecher et al.  (14)  found labeled  C lq in monocyte cultures. They realized that 
although  microgram  quantities  of  newly  synthesized  protein  could  be  detected 
technical limitations such as nonspecific binding could occur and neither net synthesis 
nor  biological  function  could  be  demonstrated  by  this  technique.  Using  similar KATHERINE  M.  MORRIS,  HARVEY  R.  COLTEN,  AND DAVID H.  BING 
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FIG.  3.  SDS-PAGE  of immunoprecipitates  o.f reduced  and  alkylated  Clr.  (a)  Fetal  intestine 
columnar epithelial cell culture medium (10 ~Ci/ml all-amino acids;  24 h); 5.0% polyacrylamide 
gels; peak A: 145,000, peak B: 90,000.0, anti-Clr; O, anti-lgG. (b) Monocyte culture medium (100 
~tCi/ml all-amino acids;  24 h);  7.5% polyacrylamide; peak A: 85,000, peak B: 33,000. A, anti-Clr; 
A, anti-IgG. 
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FIG. 4.  SDS-7.5%-PAGE  of an immunoprecipitate of reduced and  alkylated Cls. (a)  Monocyte 
culture medium  (100 #Ci/ml 3H-amino acids;  24 h);  peak A: 80,000, peak B:  13,000-40,000. A, 
anti-Cls; A, anti IgG. (b) Fibroblast  culture medium (100 #Ci/ml all-amino acids; 24 h); peak A: 
130,000. 0, anti-Cls; (>, anti-IgG. 
techniques others have also suggested that monocytes or macrophages synthesize C I q 
(15,  16). Loos et al. (17) provided equally convincing evidence that macrophages were 
sites of C1 synthesis. Re~.ently, A1-Adnani and McGee (18) demonstrated synthesis of 
Clq  by lung and skin fibroblasts by immunoprecipitation of culture medium and 
with an immunohistochemical method demonstrated Clq on the surface of these cells. 
Reid and Solomon (19) provided additional evidence for synthesis of C 1 by fibroblasts. 
They detected both  functionally active C1  and identified the radiolabeled protein 
and subunits on SDS-PAGE analyses of immunoprecipitates of each of the subcom- 
ponents. 
We have compared the capacity of these different cell types to synthesize C 1 to 
resolve these apparent differences. Epithelial cells synthesized and secreted 400-3,700 1016  Cl  SYNTHESIS BY EPITHELIAL AND MESENCHYMAL CELLS 
times more hemolytically active C1  than  fibroblasts or monocytes. Synthesis of C1 
and  its  subcomponents  by  transitional  epithelial  cells,  as  assessed  functionally  or 
immunoehemicaUy, was inhibited by cycloheximide. Moreover, the C 1 produced by 
transitional or columnar epithelial cells bound to and eluted from IgG-Sepharose in 
a  manner analogous  to serum  C1.  Immunochemical and  physicoehemical analyses 
provided evidence that C 1  q from columnar epithelial cell cultures and C 1  r from each 
of the cell types tested had subunit structures similar to serum C 1  q and Clr. The C l s 
produced  by  epithelial  cells  and  monocytes  had  subunits  approximating  those  of 
human Cls  (CI~). Clq excreted by all cultures except columnar epithelium had an 
apparent molecular size greater than serum C lq (2). C 1~ from fibroblast medium had 
subunits with larger apparent molecular sizes than the reported subunit sizes of C lq 
or CI~ isolated from serum (2,  7). 
The C1  hemolytic activity in medium from primary transitional epithelial, paren- 
chymal, and tumor cell cultures from biopsy samples was similar to that found in low 
passage  epithelial  cell  cultures.  C1  hemolytic activity  produced  by three  different 
fibroblast cultures  ranged from  17-121  effective C1  molecules/cell per h.  Reid and 
Solomon (19)  reported similar rates of CI production  (50-230 em/cell per h). These 
values are close to the lower limit of the hemolytic assay. In contrast, fetal intestinal 
columnar epithelial cells produced 4.83  ×  104 era/cell per h. These results agree with 
those reported by Bing et al. (13) and Cohen et al. (10)  for transitional and columnar 
epithelial  cells.  Production  of hemolytically active C1  by blood  monocytes  (29-83 
em/cell  per  h)  can  only  be  compared  to  other  cultures  by  accounting  for  their 
decreased protein synthesis  (Table II). They synthesized  3.6 times less total protein 
(TCA  ppt  cpm/cuhure)  than  epithelial  cells  and  4.4  times  less  than  fibroblasts. 
However, monocytes produced approximately 400-760  times less C1  than epithelial 
cells and three to seven times as much C1 as fibroblasts. C1  was present in both the 
activated  and  zymogen  form  in  epithelium  culture  medium.  To  determine  if an 
inhibitor  of C1  hemolytic  activity  was  present  in  fibroblast  culture  medium,  the 
ability of medium from two different skin fibroblast cultures to inhibit C 1 hemolytic 
activity was  measured.  No  inhhibition  was observed. The possibility that  Clr  and 
Cls but  not Clq were being synthesized was also tested. Addition  of 10/lg purified 
C lq to fibroblast or monocyte medium produced no C 1 hemolytic activity (<2.1  X 
107 em/eulture).  These results were different  than  those of Reid and  Solomon  (19) 
who  found  that  addition  of Clq  to  fibroblast culture  medium  with  low  hemolytic 
activity  (<1  X  108 em/ml)  increased  the  level  to  1-5  X  t09 em/ml.  Addition  of 
purified C ls to monocyte or fibroblast culture  medium did not  generate additional 
hemolytic activity. 
Unlike  all other cell  types tested,  intestinal  columnar epithelial  cells synthesized 
and  secreted  Clq  with  a  subunit  structure  analogous  to serum  Clq.  Clq  isolated 
from bladder  transitional  epithelium,  fibroblast  and  monocyte culture  media con- 
tained radiolabeled peaks on SDS-PAGE gels with molecular weights higher than the 
subunits  of serum  Clq.  A  peak  of approximately  180,000  daltons  was  found  in 
transitional epithelial and fibroblast media while a 78,000 dalton subunit was present 
in monocyte culture  medium. These could represent multimers of Clq  (A-B dimer, 
etc.),  precursor,  pro-Clq  molecules  or  a  molecular  species  not  normally  found  in 
serum. These results were similar to the findings of Reid and Solomon  (19)  of Clq 
subunits  with  larger  apparent  molecular weights.  C lr  and  CI~  from all  cell  types KATHERINE  M.  MORRIS, HARVEY R.  COLTEN, AND DAVID H.  BING  1017 
tested  had  apparent  molecular  weights  (Fig.  3)  which  corresponded  to  published 
reports (6, 7). The subunit structure of newly synthesized C ls (C 12) was similar in all 
cell types tested; peaks corresponding to published reports plus a heterogeneous peak 
of lower  molecular weight  subunits  suggested  degradation.  This  same explanation 
could account for some of the heterogeneous patterns observed for C lq. 
These  results  indicated  that  epithelial  cells were the  major site of hemolytically 
active C 1 biosynthesis in vitro. The capacity of columnar and transitional epithelial 
cells to produce functional C 1 was not approached by any mesenchymal cell culture 
tested  (two  to  three  logs  lower).  Fetal  intestine  columnar  epithelial  cell  cultures 
synthesized subcomponents of C 1 similar to those of serum C 1. All other culture types 
tested  produced  proteins  with  apparent  molecular  weights  both  larger  than  and 
similar  to  serum  subunits  of Clq  and  Cls.  The  hemolytic,  immunochemical,  and 
physicochemical evidence clearly demonstrated that one cell type can synthesize and 
secrete C lq,  Clr,  and  C ls.  However, caution  must  be exercised  in  interpreting  in 
vitro synthetic studies  as normal in vivo cellular regulatory mechanism are lacking. 
This lack could lead to synthesis or loss of regulation of synthesis by proteins which 
are not  normally produced  by certain cell types in  vivo. As AI-Adnani and McGee 
(18) reported, fibrohlasts synthesized and secreted C l q in vitro but attempts to detect 
Clq  in  vivo were negative until  a  pathological condition  (a silica  granuloma)  was 
induced.  The results of our in vitro studies  indicated  that columnar or transitional 
epithelial  cells  should  be  useful  for studies  of regulation  of biologically active C1 
synthesis, but transitional cells, fibroblasts, or monocytes are appropriate for investi- 
gating the precursors of C lq, C lr, and C ls. 
Summary 
Epithelial and mesenchymal cells synthesized and secreted all three subcomponents 
of the  first  component  of complement  (C1):  Clq,  Clr,  and  Cls.  Quantitatively, 
however,  columnar  and  transitional  epithelial  cells  secreted  400-3,700  times  more 
hemolytically active C 1 than monocytes or fibroblasts. Only columnar epithelial cells 
synthesized C1  subcomponents with subunit  structures similar to their serum coun- 
terparts.  Transitional epithelial cells, fibroblasts, and monocytes produced Clq and 
C ls with  subunits  of apparent  molecular weights  larger than  reported  values.  C lr 
from all cell lines was physicochemicaUy similar to serum Clr. 
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